FDA Investigator Sarah M Napier

Sarah M Napier has inspections in 5 countries as of 06 Oct 2023. Sarah M Napier has collaborated with a combinined 3957 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
62
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan, United States of America, Germany, Switzerland, Denmark
Co-Investigator(s):
Abdul K Kamara, Adam J Wilson, Alan M Roberts, Alanna Lmussawwir Bias, Aldo J Quintana, Alexandra A Carrico, Alice S Tsao, Amy S Graf, Andrea F White, Anita Narula, PhD, Ann Raju Daniel, Anna Lazar, Anthony F Lorenzo, Anthony R Petriella, Art O Czabaniuk, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Barbara J Rincon, Bei Y He, Benjamin J Smith, Bernice F Hirsch, Brentley S Collins, Burnell M Henry, Carla V Jordan, Carmen M Faraianu, Caroline H Le, Catherine V Quinlan, Cathie S Marshall, Charles I Ann, Charles L Zhou, Charles M Edwards, Charles M Spyr, Cheng H Yen, Cheryl A Fuhs, Cheryl M Monroe, Christian D Lynch (CDL), Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Cynthia A Palmer, Cynthia L Aycock, Cynthia Li, Danial S Hutchison, Daniel J Brown, Daniel J Grabicki, Danielle S Mills, Darren S Morgan, David A Paterson, David J Gasparovich, David P Moorhead, David Perkins, Dawn C Olenjack, Deborah M Trout, Eliezar Ramos, Elizabeth M Kelley, Emest F Bizjak, Emilie E Kahn, Emilie E, Kahn, Emily J Orban, Enrico Joset Mangahis, Eric S Pittman, Franklin D Heisler, French, Gary C Pecic, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, Ginger M Sykes, Hans T Meyers, Hartman, Hassan M Fakhreddine, Helen B Ricalde, Hokenson, Ifueko Osemwota, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James E Szelc, James K Ireland, James R Evans, Janet L Bowen, Jeannie M Melin, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Schmidt, Jogy George, John N Woodall, Joneson, Joohi Castelvetere, Joseph A Piechocki, Joseph T Madak, Karen K Moksnes, Karen Takahashi, Kathryn A Cutajar, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Kelly A Sparks, Kham Phommachanh, Khoa Nathanv Tran, Kristina Nastovski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Lata C Mathew, PhD, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren M Lilly, PhD, Leslie A Paul, Linda S Jozefiak, Lindsey Brown, PhD, Lisa J Joseph, Lisa J Renick, Lisa M Bellows, Lisa M Feola, Lisa M Thursam, Lisa P Oakes, Lisa T Michel, Logan M Ebeling, Logan T Williams, LT Skip A Payne, LTJG Aaron B Otis, Luis M Burgos Medero, Mark R Mcclain, Marlon K Turner, Martha Sullivan Mynck, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Megan C Amye, Megan C Spencer, Meisha R Sampson, Meisha Waters, Miah I Schneider, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Minerva Rivera, Myra K Casey, Natalie A Mickelsen, DVM, Nicholas E Boyd, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Paraluman S Leonin, Paranthaman Senthamaraikannan, Patsy I Domingo, Patsy J Domingo, Paula A Trost, Peng Zhou, Philip A Klimkewicz, Prabhu P Raju, Rabin N Ghoshal, Ralph A Erickson, Rasha Bamieh, Raymond R Roy, PhD, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Richard W Thornton, Robert C Coleman, Robert J Ham, Robert M Barbosa, Robert P Whisenant, Robert R Barbosa, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Ronald G Crawford, Rose M Ashley, Ryan J Benedict, Saied A Asbagh, Salwa K Poole, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott T Ballard, Sean R Bryd, Sharon K Thoma, PharmD, Sheryl A Duquet, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, State Agency, Steven D Kehoe, Susan M Jackson, Susan P Bruederle, Suyang Qin, Theodore N Sietsema, Thomas A Peter, Thomas E Friel, Thomas J Arista, Thomas J Cosgrove, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Vanessa J Colburn, Veronica Fuentes, MS, Vesa Vuniqi, Victoria A Murray, William A Warnick, William D Tingley, William G Nelson, Yumi J Hiramine

Sarah M Napier's Documents

Publish Date Document Type Title
March, 2014 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2014-03-13
January, 2013 FDA 483 Wayne Concept Manufacturing Co Inc - Form 483, 2013-01-10
September, 2010 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2010-09-28
August, 2013 FDA 483 Lannett Company, Inc. - Form 483, 2013-08-27
November, 2014 FDA 483 Response Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483R, 2014-11-13
November, 2012 EIR Kath Khemicals LLC - EIR, 2012-11-01
December, 2014 FDA 483 Coram Healthcare Corp. of Indiana - Form 483, 2014-12-16
August, 2012 FDA 483 DSC Laboratories, LLC - Form 483, 2012-08-31
April, 2014 FDA 483 Zoetis LLC - Form 483, 2014-04-17
May, 2013 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2013-05-30
September, 2012 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2012-09-27
June, 2011 FDA 483 DDP Specialty Electronic Materials US 9, LLC - Form 483, 2011-06-29
June, 2012 FDA 483 Accra Pac, Inc. dba Voyant Beauty - Form 483, 2012-06-07
May, 2010 FDA 483 Tower Laboratories Ltd - Form 483, 2010-05-12
March, 2012 FDA 483 Par Sterile Products LLC - Form 483, 2012-03-29
September, 2014 FDA 483 L. Perrigo Company - Form 483, 2014-09-04
May, 2012 FDA 483 Biological Research Solutions, Inc. - Form 483, 2012-05-24
December, 2012 FDA 483 King Pharmaceuticals LLC - Form 483, 2012-12-13
August, 2010 FDA 483 Aurorium LLC - Form 483, 2010-08-27
March, 2013 FDA 483 Xela Pack, Inc. - Form 483, 2013-03-01
June, 2011 FDA 483 Par Sterile Products LLC - Form 483, 2011-06-08
November, 2014 FDA 483 Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483, 2014-11-13
March, 2011 FDA 483 King Pharmaceuticals LLC - Form 483, 2011-03-16
November, 2011 FDA 483 Painexx Corporation - Form 483, 2011-11-09
November, 2010 FDA 483 Kath Khemicals LLC - Form 483, 2010-11-24
January, 2013 EIR Wayne Concept Manufacturing Co Inc - EIR, 2013-01-10
July, 2013 FDA 483 Beacon Hill Medical Pharmacy, P.C. - Form 483, 2013-07-19
May, 2013 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2013-05-10
June, 2010 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2010-06-28
May, 2012 EIR Biological Research Solutions, Inc. - EIR, 2012-05-24
September, 2012 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2012-09-27
March, 2011 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2011-03-25
May, 2013 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2013-05-10
November, 2012 FDA 483 Kath Khemicals LLC - Form 483, 2012-11-01
March, 2013 FDA 483 Corteva Agriscience LLC - Form 483, 2013-03-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more